Bonferroni-based correction factor for multiple, correlated endpoints

Pharmaceutical Statistics

Volumn 11, Issue 4, 2012, Pages 300-309

  Shi, Qian ^a   Pavey, Emily S ^a   Carter, Rickey E ^a  

^a MAYO CLINIC   (United States)

Author keywords

Bonferroni correction; correlated data; multiple endpoints; power; type I error rate

Indexed keywords

CANNABIS;

ARTICLE; BONFERRONI CORRECTION METHOD; BOOTSTRAPPING; CANNABIS ADDICTION; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; POWER ANALYSIS; PUBLICATION; STATISTICAL ANALYSIS; WITHDRAWAL SYNDROME;

CLINICAL TRIALS AS TOPIC; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; ENDPOINT DETERMINATION; HUMANS; MARIJUANA ABUSE; RESEARCH DESIGN;

EID: 84863724227     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.1514     Document Type: Article

References (17)

1. Food and Drug Administration. Guidance for industry: E9 statistical principles for clinical trials. Technical report, Food and Drug Admnistration, 5600 Fishers Lane, Rockville, MD 20857, 1998. Available at:.
2. Ward WL, Hahn EA, Mo F, Hernandez L, Tulsky DS, Cella D,. Reliability and validity of the functioanl assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument. Quality of Life Research 1999; 8: 181-195. (Pubitemid 29367288)
3. Holm S,. A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics 1979; 6: 65-70.
4. Hommel G,. A stagewise rejective multiple procedure based on a modified bonferroni test. Biometrika 1988; 75: 383-386.
5. Marcus R, Peritz E, Gabriel KR,. On closed testing procedures with special reference to ordered analysis of variance. Biometrika 1976; 63: 655-660.
6. Liu W,. Multiple tests of a non-hierarchical finite family of hypotheses. Journal of the Royal Satisticial Society, Series B 1996; 58: 455-461.
7. Westfall PH, Krishen A,. Optimally weighted, fixed sequence, and gatekeeping multiple testing procedures. Journal of Statistical Planning and Inference 2001; 99: 25-40. (Pubitemid 33619467)
8. Dmitrienko A, Offen W, Westfall PH,. Gatekeeping strategies for clinical trials that do not require all primary effects to be significant. Statistics in Medicine 2003; 22: 2387-2400. (Pubitemid 36949661)
9. Carter RE,. A simple illustration for need of multiple comparison procedures. Teaching Statistics 2010; 32(3): 90-1.
10. Neuhauser M,. How to deal with multiple endpoints in clinical trials. Fundamental & Clinical Pharmacology 2006; 20: 515-523. (Pubitemid 44760171)
11. Heishman SJ, Singleton EG,. Assessment-216 of cannabis craving using the marijuana craving questionnaire. Methods in Molecular Medicine 2006; 123: 209.
12. Heishman SJ, Evans RJ, Singleton EG, Levin KH, Copersino ML, Gorelick DA,. Reliability and validity of a short form of the marijuana craving questionnaire. Drug and Alcohol Dependence 2009; 102 (1-3): 35-40.
13. Westfall PH, Young SS,. Resampling-based multiple testing: examples and methods for p-value adjustment. John Wiley & Sons. Inc.: New York, NY, 1993.
14. Casella G, Berger R,. Statistical Inference, 2nd ed. Duxbury: Thomson, Brooks/Cole, Pacific Grove, CA, 2002.
15. Donner A, Klar N,. Design and analysis of cluster randomization trials in health research. John Wiley & Sons. Inc.: New York, NY, 2000.
16. Westfall PH, Tobias RD, Rom D, Wolfinger RD, Hochberg Y,. Multiple comparisons and multiple tests using the SAS system. Cary, NC: SAS Institute Inc., 1999.
17. Clayton DG,. A model for association in bivariate life tables and its application in epidemiological studies of familial tendency in chronic disease incidence. Biometrika 1978; 65: 141-151. (Pubitemid 8308396)